Barclays
LFST icon

Barclays’s Lifestance Health LFST Stock Holding History

Barclays’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$369K – 5418
2024
Q4 		$369K Hold
50,000
– – ﹤0.01% 4006
2024
Q3 		$350K Hold
50,000
– – ﹤0.01% 3986
2024
Q2 		$246K Hold
50,000
– – ﹤0.01% 3466
2024
Q1 		$309K Buy
+50,000
New +$337K ﹤0.01% 3882

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Barclays's LFST Position: Q1 2026 in Review

Barclays reduced its Lifestance Health (LFST) stake by 20% in Q1 2026, selling an estimated $4.94M and leaving 2,765,692 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1160.

Barclays first reported a position in LFST in Q1 2022 and has held it in 17 quarters since. The position peaked at $24.5M in Q4 2025. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Barclays held 2,765,692 shares of Lifestance Health worth $17.6M as of Q1 2026.
  • Barclays sold 709,803 Lifestance Health shares in Q1 2026, an estimated $4.94M.
  • Lifestance Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1160 holding.
  • Barclays first reported a position in Lifestance Health in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Lifestance Health position peaked at $24.5M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.